General
South Africa to suspend rollout of AstraZeneca coronavirus vaccine
South Africa was set to suspend the rollout of the AstraZeneca vaccine after trial data showed the jab offered limited protection against mild disease caused by B.1.351, the coronavirus variant first identified in the country.
Key points:
- Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against the South Africa variant
- Vaccine lead researcher Sarah Gilbert said the company expected to have a new jab to cope with the variant by September
- Federal Health Minister Greg Hunt said he was not concerned about vaccine
Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against mild disease caused by the South Africa variant.
But the…
Continue Reading
-
Noosa News23 hours agoSecurity concerns over Chinese-made Yutong fleet dismissed
-
Noosa News23 hours agoEx-Townsville mayor Troy Thompson lied about army service, degrees, and cancer, says CCC
-
General16 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General15 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting